NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

This session will focus on requirements for de-identification outside of the United States.

Session

...

4: Industry Approaches to De-Identification

Session chair: Keyvan Farahani, PhD, Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health

...

David Clunie, MBBS, PixelMed, LLC

Session

...

5: Pathology Whole Slide Image De-Identification

Session chair: Mark ElliotAdam Taylor, PhD, University of ManchesterSage Bionetworks

In this session, researchers will discuss how to analyze the re-identification risk of indirect identifiers in medical imagespathology whole slide image de-identification.

Session

...

6: De-facing

Session chair: Ying Xiao, Ph.D. Hospital of the University of Pennsylvania

...

Estimated at 11:50 a.m. - 12:00 p.m.

Session

...

7:

...

The Role of Artificial Intelligence in De-Identification

Session chair: Judy Wawira Gichoya, MD, MS, Emory University

In this session, researchers discuss the utility and risk of using algorithms from machine learning (ML) and artificial intelligence (AI) to de-identify medical images.

Session

...

8: Panel Discussion

Session chair: Jürgen Klenk, PhD, Deloitte Consulting LLP

...